NCT02642042 2026-03-04Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting60 enrolled 24 charts